A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma. - Concepedia

Concepedia

Publication | Closed Access

A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.

121

Citations

29

References

2003

Year

James Posey, Thian C. Ng, Baolian Yang, M.B. Khazaeli, Mark Carpenter, Floyd E. Fox, Mike Needle, Harlan W. Waksal, Albert F. LoBuglio

Abstract

IMC-1C11 was both safe and well tolerated. Drug levels of IMC-1C11 were reliably predicted. Further clinical investigation of anti-VEGFR/KDR agents is warranted.

References

	Year	Citations

Page 1